-+ 0.00%
-+ 0.00%
-+ 0.00%

CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate

Benzinga·05/14/2026 12:28:24
Listen to the news
CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(7.30) per share which missed the analyst consensus estimate of $(5.37) by 35.94 percent. This is a 61.44 percent increase over losses of $(18.93) per share from the same period last year.